Migraine treatment is focus of Mayo PCORI grant
A Mayo Clinic research team led by Todd Schwedt, M.D. (HEAD ’06), and David Dodick, M.D. (I’1 ’91, N ’94), Department of Neurology at Mayo Clinic in Arizona, has been approved for $7 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to study migraine treatment strategies.
The five-year study, beginning later this year, will compare two commonly used treatment strategies for patients who have chronic migraine with medication overuse in an aim to determine the optimal treatment approach.
The 1,200 patients in the study will be enrolled from all Mayo campuses and 30 sites across the country.